YOLFTbeta
Zhejiang CONBA Pharmaceutical Co Ltd

Zhejiang CONBA Pharmaceutical Co Ltd

600572 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

4.12CNY-0.02 (-0.48%)

Price History

Full chart

Market Stats

Previous Close4.14
Open4.15
Day Range4.11 – 4.18
52-Week Range3.77 – 5.17
Volume40.85M
Market Cap10.94B
P/E (TTM)21.55
Forward P/E21.46
EPS0.20
Dividend Yield3.48%
Beta0.21
50-Day Avg4.37
200-Day Avg4.37

About

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company offers its products under Aokang, Jindi, Jinaikang, Qianliekang, Tianbaoning, Jinkang Su, Li, Zhixinyan, Kang Enbei, Baozhilin, and Yangyingtang brands. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ming Chen
  • Employees7.83K
  • HeadquartersBinjiang Science and Technology Economic Park, Hangzhou, China, 310051, China
  • Websitehttps://www.conbapharm.com

Leadership

  • Mr. Ming ChenVP, CFO & Financial Controller · b. 1977
  • Mr. Jianfeng YeVP & Director · b. 1974
  • Mr. Zucheng JinVP & Board Secretary · b. 1976
  • Mr. Shishui YinVice President · b. 1975

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue386.75M440.81M468.79M603.10M866.41M1.28B1.24B1.09B1.41B1.89B2.26B2.73B2.92B3.58B5.30B6.02B5.29B7.02B6.77B5.91B6.57B6.00B6.73B6.52B6.47B
Growth (%)-+13.98%+6.35%+28.65%+43.66%+47.66%-3.26%-11.53%+28.46%+34.51%+19.45%+20.96%+6.97%+22.48%+48.03%+13.55%-12.07%+32.57%-3.56%-12.70%+11.16%-8.64%+12.20%-3.23%-0.64%
Cost of Revenue151.57M184.18M220.24M322.04M448.85M385.57M558.27M515.96M606.60M689.99M725.00M911.56M943.12M1.10B2.48B3.16B1.46B1.69B1.73B2.09B2.63B2.47B2.84B3.10B3.02B
Gross Profit235.18M256.63M248.56M281.06M417.55M686.60M679.33M578.95M799.94M1.18B1.40B1.82B1.98B2.48B2.82B2.86B3.83B5.33B5.04B3.82B3.94B3.53B3.90B3.41B3.45B
Gross Margin60.81%58.22%53.02%46.60%48.19%53.67%54.89%52.88%56.87%62.30%61.85%66.65%67.75%69.16%53.17%47.55%72.42%75.91%74.41%64.66%60.02%58.84%57.89%52.41%53.31%
Operating Expense188.82M201.47M202.37M231.57M368.93M574.80M555.87M535.30M695.35M986.20M1.13B1.47B1.50B1.68B2.26B2.39B2.93B4.28B5.08B3.04B1.41B2.93B3.11B2.62B2.83B
Operating Income46.36M55.16M46.19M49.48M48.63M111.80M123.46M43.65M104.58M192.46M264.74M347.56M480.11M800.36M563.45M476.39M908.64M1.05B-39.07M783.94M2.53B602.46M788.27M798.89M624.18M
Operating Margin11.99%12.51%9.85%8.21%5.61%8.74%9.98%3.99%7.44%10.17%11.71%12.71%16.42%22.35%10.63%7.91%17.16%14.92%-0.58%13.27%38.59%10.04%11.71%12.26%9.64%
EBITDA70.06M72.36M64.99M100.93M119.79M203.67M253.78M127.04M175.79M330.48M370.70M435.69M519.47M785.14M1.06B909.81M1.21B1.33B1.18B847.64M956.65M963.34M1.13B913.75M997.71M
EBITDA Margin18.12%16.42%13.86%16.73%13.83%15.92%20.51%11.60%12.50%17.47%16.40%15.94%17.76%21.92%19.94%15.11%22.85%18.94%17.41%14.34%14.56%16.05%16.76%14.02%15.41%
Net Income42.33M41.83M40.07M28.63M43.63M84.41M106.13M91.97M101.22M194.97M280.23M295.71M417.37M552.35M440.37M441.07M711.12M815.16M-345.63M453.30M2.02B358.12M591.57M622.42M474.36M
Net Income Margin10.94%9.49%8.55%4.75%5.04%6.60%8.58%8.40%7.20%10.31%12.40%10.82%14.27%15.42%8.31%7.33%13.43%11.62%-5.11%7.67%30.72%5.97%8.79%9.55%7.33%
R&D---------54.51M47.44M72.52M92.88M106.20M120.74M132.18M151.10M184.69M183.02M184.99M202.49M195.72M298.09M300.02M262.22M
R&D as % of Total Revenue---------2.88%2.10%2.65%3.18%2.97%2.28%2.20%2.85%2.63%2.70%3.13%3.08%3.26%4.43%4.60%4.05%
Interest Expense7.35M9.01M8.04M13.58M19.03M37.11M40.35M28.52M22.57M28.34M37.83M60.70M77.02M88.60M139.71M124.13M67.77M95.18M152.26M124.93M74.23M50.58M37.43M21.85M7.79M
Interest Expense % of Total Revenue1.90%2.04%1.72%2.25%2.20%2.90%3.26%2.61%1.60%1.50%1.67%2.22%2.63%2.47%2.64%2.06%1.28%1.36%2.25%2.11%1.13%0.84%0.56%0.34%0.12%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets447.63M462.63M581.65M981.41M1.16B1.26B1.55B1.57B1.93B2.46B2.96B4.54B4.45B6.30B9.57B8.50B9.42B10.71B9.86B9.28B10.79B10.93B11.24B9.90B9.98B
Total Liabilities265.74M261.88M342.22M416.37M560.55M628.20M693.32M649.60M780.76M747.34M1.35B2.10B1.86B2.93B5.00B4.01B3.58B4.92B4.92B3.93B3.40B3.61B3.89B2.99B2.83B
Total Equity178.30M197.20M237.57M517.98M534.17M562.60M846.11M911.16M997.30M1.54B1.42B2.17B2.37B2.79B4.14B4.30B5.73B5.65B4.66B5.03B7.06B6.91B7.04B6.82B7.05B
Cash137.84M103.92M137.70M327.99M329.02M270.31M374.91M360.46M316.34M672.05M720.32M1.55B782.00M668.94M1.80B1.91B2.17B1.58B1.69B1.58B2.49B2.47B2.57B1.32B1.67B
Total Debt167.41M185.68M226.99M260.66M362.74M428.66M453.68M426.50M447.75M373.00M829.70M1.33B1.06B1.76B2.46B1.99B1.60B2.54B2.68B2.36B1.49B1.20B953.91M330.47M-
Net Debt29.57M81.76M89.29M-67.33M33.72M158.35M78.77M66.04M131.41M-299.05M109.38M-222.64M277.95M1.09B661.50M78.66M-564.04M962.79M992.29M785.82M-1.00B-1.27B-1.53B-991.64M-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--66.64M65.47M117.65M71.20M79.98M98.56M153.39M125.93M188.36M245.76M235.36M617.43M831.26M969.71M712.27M545.78M925.50M1.25B889.94M1.16B898.64M1.01B942.61M
Investing Cash Flow--73.50M-66.64M-97.34M-162.22M-105.88M3.41M-27.20M-79.19M-49.27M-515.20M-509.87M-404.29M-1.26B-1.22B480.96M-537.82M-1.71B-141.41M-166.77M1.10B-211.11M-289.05M-211.50M-
Financing Cash Flow--7.43M13.24M222.17M45.97M-23.99M9.23M-84.91M-119.10M280.18M362.53M1.08B-628.71M540.83M887.57M-702.37M63.54M202.84M-626.52M-1.03B-1.02B-924.71M-719.08M-1.91B-
Capital Expenditure076.99M40.34M63.81M116.57M65.67M81.83M81.12M53.32M113.07M133.09M239.76M476.32M429.23M286.97M231.83M291.80M379.63M268.79M460.40M568.37M291.75M209.14M290.63M147.26M
Free Cash Flow--76.99M26.30M1.66M1.08M5.53M-1.84M17.44M100.07M12.86M55.27M6.00M-240.97M188.20M544.29M737.88M420.47M166.15M656.71M789.30M321.56M863.73M689.50M721.90M795.35M
Dividends Paid-34.48M28.86M71.07M45.51M49.91M100.15M57.88M64.28M70.58M74.11M160.29M191.84M217.49M302.92M282.35M318.08M485.46M385.51M142.80M85.01M490.35M420.13M523.54M383.64M
FCF to OCF--39.46%2.54%0.92%7.76%-2.30%17.69%65.24%10.21%29.34%2.44%-102.38%30.48%65.48%76.09%59.03%30.44%70.96%63.16%36.13%74.75%76.73%71.30%84.38%
Dividend Paid to FCF--44.78%109.72%4272.09%4226.73%902.85%-5437.26%331.96%64.23%548.86%134.09%2671.29%-79.61%115.56%55.66%38.27%75.65%292.19%58.70%18.09%26.44%56.77%60.93%72.52%48.24%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Apr 22, 2013Aug 22, 2013Sep 30, 2013Feb 26, 2014Apr 21, 2014Aug 4, 2014Oct 29, 2014Feb 25, 2015Apr 22, 2015Aug 24, 2015Oct 25, 2015Mar 2, 2016Apr 12, 2016Aug 25, 2016Oct 28, 2016Apr 19, 2017Jul 11, 2017Oct 17, 2017Apr 27, 2018Jul 11, 2018Oct 28, 2018Apr 24, 2019Aug 21, 2019Oct 30, 2019Apr 27, 2020Aug 21, 2020Oct 28, 2020Apr 20, 2021Aug 20, 2021Oct 29, 2021Apr 21, 2022Aug 25, 2022Oct 26, 2022Apr 14, 2023Dec 31, 2023Apr 19, 2024
EPS Estimate------------0.030.05--0.030.060.07-0.070.09--0.04-0.060.020.09--0.080.08-------------0.020.02
EPS Actual0.020.040.020.030.060.030.030.030.030.050.030.070.030.040.050.050.030.070.040.080.010.100.07-0.070.040.060.050.020.080.090.040.100.090.010.080.03-0.310.120.02-0.040.08-0.010.700.040.010.05-0.01-0.01
Surprise------------0.00%-20.00%--0.00%16.67%-42.86%--85.71%11.11%--0.00%--16.67%0.00%-11.11%--25.00%12.50%--------------150.00%-150.00%
Timing------------After-hoursAfter-hours--After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours--After-hours--After-hours--Pre-market-After-hours

Key Statistics & Ratios

Market Cap10.94B
Enterprise Value10.00B
Trailing P/E21.55
Forward P/E21.46
Price / Sales1.61
Price / Book1.53
EPS0.20
Book Value2.78
Revenue (TTM)6.82B
Gross Profit (TTM)3.72B
EBITDA1.00B
Profit Margin7.31%
Operating Margin12.92%
Return on Equity7.36%
Return on Assets4.21%
Shares Outstanding2.54B
Shares Float1.64B
Beta0.21
Dividend Yield3.48%
Dividend Rate0.15
Payout Ratio74.26%

Dividends

20231×
0.15Jun 9, 2023
20221×
0.16Jun 29, 2022
20191×
0.15Jun 26, 2019
20181×
0.15Jul 5, 2018
20171×
0.12Jun 16, 2017
20161×
0.10Jun 15, 2016
20151×
0.11Jul 7, 2015
20141×
0.06Jun 25, 2014
20131×
0.05Jun 4, 2013
20121×
0.06Jun 19, 2012
20111×
0.04Apr 25, 2011
20101×
0.03May 19, 2010
20091×
0.02May 13, 2009
20081×
0.03Apr 15, 2008
20071×
0.03Apr 25, 2007
20061×
0.02Jun 21, 2006
20052×
0.19Dec 27, 20050.02Jun 17, 2005

Stock Splits

  • Jun 15, 20163:2
  • Jul 7, 201517:10
  • Apr 25, 20112:1
  • Apr 15, 20089:5